CRYOSYRINGE DESIGNED FOR STERILE LIQUID NITROGEN FREEZING, QUICK THAWING AND INJECTION OF CELLULAR SLURRIES
20170216531 ยท 2017-08-03
Inventors
Cpc classification
A61M5/3134
HUMAN NECESSITIES
A61M2005/3131
HUMAN NECESSITIES
A01N1/0263
HUMAN NECESSITIES
A61M2005/3117
HUMAN NECESSITIES
A61J1/1468
HUMAN NECESSITIES
A61M2005/3125
HUMAN NECESSITIES
A61M5/3135
HUMAN NECESSITIES
International classification
Abstract
An embodiment in accordance with the present invention is directed to a device for use as a cryosyringe and a cryo-storage vial. The device includes a first end and a second end and has an outer wall defining a lumen between the first and second ends. Both the first end and the second end include threads configured for attaching a first cap to the first end and a second cap to the second end. The device can also include a syringe plunger adapter, such that the cryo-storage vial is convertible into a cryosyringe to ensure sterility of the contents. Similarly, a luer-lock adapter can be included to further convert the device into a cryosyringe. The device and its components are formed from a cryo-resistant material. The device can therefore withstand liquid nitrogen temperatures necessary to preserve cell viability and be injected without compromising sterility to dispense the cellular therapy.
Claims
1. A device for storage and delivery of a sample comprising: a tube formed from a cryo-resistant material having an outer wall defining an inner lumen, the tube also having a first end and a second end, wherein the first and second ends define openings, wherein the openings are in communication with the lumen; a first end cap configured to couple with the first end of the tube, and wherein the first end of the tube is configured to couple with the first end cap, such that the first end cap seals the first opening of the tube; a second end cap configured to couple with the second end of the tube, and wherein the second end of the tube is configured to couple with the second end cap, such that the second end cap seals the second opening of the tube; and wherein the tube, the first end cap, and the second end cap are all formed from a cryo-resistant material.
2. The device of claim 1 wherein the first and second ends of the tube are threaded.
3. The device of claim 2 wherein the first and second end caps are threaded, such that they couple to the first and second ends of the tube.
4. The device of claim 1 wherein the cryo-resistant material is a medical-grade polypropylene.
5. The device of claim 1 wherein the device includes a syringe plunger adapter.
6. The device of claim 1 wherein the device includes a luer-lock adapter.
7. The device of claim 1 wherein the device includes a cryo-resistant gasket positioned at the first end of the tube.
8. The device of claim 7 wherein the cryo-resistant gasket is configured to create a seal between the first end and the first end cap.
9. The device of claim 1 wherein the device includes a cryo-resistant gasket positioned at the second end of the tube.
10. The device of claim 9 wherein the cryo-resistant gasket is configured to create a seal between the second end and the second end cap.
11. The device of claim 1 wherein the tube includes gradations.
12. The device of claim 11 wherein the gradations are formed by one selected from a group consisting of printing, pressing, etching, or engraving on the tube.
13. The device of claim 1 wherein the cryo-resistant material is configured to withstand liquid nitrogen temperatures.
14. The device of claim 1 wherein the device is configured to dispense its contents without a change of container.
15. The device of claim 1 wherein the cryo-resistant material is a plastic.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0008] The accompanying drawings provide visual representations, which will be used to more fully describe the representative embodiments disclosed herein and can be used by those skilled in the art to better understand them and their inherent advantages. In these drawings, like reference numerals identify corresponding elements and:
[0009]
[0010]
DETAILED DESCRIPTION
[0011] The presently disclosed subject matter now will be described more fully hereinafter with reference to the accompanying Drawings, in which some, but not all embodiments of the inventions are shown. Like numbers refer to like elements throughout. The presently disclosed subject matter may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Indeed, many modifications and other embodiments of the presently disclosed subject matter set forth herein will come to mind to one skilled in the art to which the presently disclosed subject matter pertains having the benefit of the teachings presented in the foregoing descriptions and the associated Drawings. Therefore, it is to be understood that the presently disclosed subject matter is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims.
[0012] An embodiment in accordance with the present invention is directed to a device for use as a cryosyringe and a cryo-storage vial. The device includes a first end and a second end and has an outer wall defining a lumen between the first and second ends. Both the first end and the second end include threads configured for attaching a first cap to the first end and a second cap to the second end. The device can also include a syringe plunger adapter, such that the cryo-storage vial is convertible into a cryosyringe to ensure sterility of the contents. Similarly, a luer-lock adapter can be included to further convert the device into a cryosyringe. The device and its components are formed from a cryo-resistant material. The device can therefore withstand liquid nitrogen temperatures necessary to preserve cell viability and be injected without compromising sterility to dispense the cellular therapy.
[0013]
[0014]
[0015]
[0016] The present invention minimizes the effort, cost, and labor of fill and finish for cellular therapies. The present invention also obviates the need to verify sterility after freezing of cells destined for cellular therapy, because the sterility of the cells is never compromised by changing containers. Generally, cells are washed and transferred to a new syringe for administration to the patient. The present invention eliminates the need for such a process.
[0017] The many features and advantages of the invention are apparent from the detailed specification, and thus, it is intended by the appended claims to cover all such features and advantages of the invention, which fall within the true spirit and scope of the invention. Further, since numerous modifications and variations will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation illustrated and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the invention.